Tobias Gedde-Dahl

7PUBLICATIONS
72CO-AUTHORS
HaematologyMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies.

Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello

|Aug 05, 2024
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS.

Esteban Arrieta-Bolaños, Lars L J van der Burg, Tobias Gedde-Dahl

|Jul 15, 2024
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms.

Yves Chalandon, Diderik-Jan Eikema, Ivan Moiseev

|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Christof Scheid, Diderik-Jan Eikema, Michel van Gelder

|Apr 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.

Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell

|Aug 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party.

Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl

Pageof 2

Frequent Collaborators

5 joint publications

Ibrahim Yakoub-Agha

4 joint publications

Marie Robin

4 joint publications

Nicolaus Kröger

3 joint publications

Liesbeth C de Wreede